These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32592372)

  • 41. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary cultures of human colon cancer as a model to study cancer stem cells.
    Koshkin S; Danilova A; Raskin G; Petrov N; Bajenova O; O'Brien SJ; Tomilin A; Tolkunova E
    Tumour Biol; 2016 Sep; 37(9):12833-12842. PubMed ID: 27449036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer stem cells in colorectal cancer: a review.
    Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T
    J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma.
    Chen DQ; Huang JY; Feng B; Pan BZ; De W; Wang R; Chen LB
    PLoS One; 2014; 9(10):e109578. PubMed ID: 25279705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thioridazine elicits potent antitumor effects in colorectal cancer stem cells.
    Zhang C; Gong P; Liu P; Zhou N; Zhou Y; Wang Y
    Oncol Rep; 2017 Feb; 37(2):1168-1174. PubMed ID: 28000884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
    Hu J; Cai G; Xu Y; Cai S
    Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116.
    Kukcinaviciute E; Jonusiene V; Sasnauskiene A; Dabkeviciene D; Eidenaite E; Laurinavicius A
    J Cell Biochem; 2018 Jul; 119(7):5913-5920. PubMed ID: 29637602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
    Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
    Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of Differentially Expressed MicroRNAs involved in the Pathogenesis of Colorectal Cancer.
    Feng H; Xu M; Zhang Y; Han B; Wang J; Sun P
    Clin Lab; 2018 May; 64(5):797-804. PubMed ID: 29739047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
    Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
    Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
    Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
    Zhao Y; Wang C; Goel A
    Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
    Chiaro C; Lazarova DL; Bordonaro M
    Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
    Wei F; Zhang T; Yang Z; Wei JC; Shen HF; Xiao D; Wang Q; Yang P; Chen HC; Hu H; Chen ZP; Huang Q; Li WL; Cao J
    Cell Physiol Biochem; 2018; 46(2):829-846. PubMed ID: 29627822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism.
    Dai A; Guo X; Yang X; Li M; Fu Y; Sun Q
    J Cancer Res Ther; 2022 Sep; 18(5):1328-1337. PubMed ID: 36204880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.